Biomarker Lens

Common biomarkers

  • Hemoglobin
  • Glucose
  • ALT
  • Apolipoprotein B
  • C-Reactive Protein, Cardiac
  • Ferritin
  • Alb/Creat Ratio, Urine
  • Alkaline Phosphatase
  • FSH
  • T4,Free(Direct)

Biomarkers · Chemical

Fibrosis Score

LOINC codes
48795-9
Tests that measure Fibrosis Score
Labcorp 6, Quest Diagnostics 1

Ranges

Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ

Labcorp, Hepatitis C Virus (HCV) FibroSure® 550123

PopulationInterval
Fibrosis Stage (FibroTest)Range
F0−No fibrosis0.00−0.21
F0−F1>0.21−0.27
F1−Portal fibrosis>0.27−0.31
F1−F2>0.31−0.48
F2−Bridging fibrosis with few septa>0.48−0.58
F3−Bridging fibrosis with many septa>0.58−0.72
F3−F4>0.72−0.74
F4−Cirrhosis>0.74−1.00
Activity Stage (ActiTest)Range
A0−No activity0.00−0.17
A0−A1>0.17−0.29
A1−Minimal activity>0.29−0.36
A1−A2>0.36−0.52
A2−Moderate activity>0.52−0.60
A2−A3>0.60−0.63
A3−Severe activity>0.63−1.00

Labcorp test catalog, 550123

Tests

Check the catalog code, specimen, method and preparation for every test that measures Fibrosis Score. Select up to five tests to compare them side by side.

Labcorp 6 tests

Single-analyte tests

  • Enhanced Liver Fibrosis (ELF)™ Test 550659

    Serum · Fasting not stated · Turnaround 3 - 6 days

    Method and collection
    Method
    The ELF™ test consists of three fully automated, two-site sandwich immunoassays using direct chemiluminometric technology. The component assays use two monoclonal mouse antibodies: The first antibody is an acridinium ester-labeled antibody. The second antibody is a biotin-labeled antibody. The solid phase contains streptavidin-coated paramagnetic particles. The ELF™ score is derived from an algorithm that combines PIIINP, TIMP-1, and HA. ELF™ is a trademark of Siemens Healthcare Diagnostics.
    Collection
    Complete clot formation should take place before centrifugation. Serum should be physically separated from cells as soon as possible with a maximum limit of two hours from the time of collection.
    Reference notes
    ELF™ Score Interpretation: Risk cut-offs to assess the likelihood of progression to cirrhosis and liver-related clinical events within 3.9 years following baseline ELF score (IQR: 14.0-22.4 months):5 Lower risk | <9.80 Mid risk | 9.80–11.29 Higher risk | >11.29 Note: The ELF™ Score is a unitless numerical value.
    Labcorp catalog page

Panels that include this biomarker

  • Hepatitis B Virus (HBV) FibroSure® 550605

    8 analytes · Serum · Fasting not stated · Turnaround 3 - 5 days

    Method and collection
    Method
    See individual test components.
    Preparation
    Patient should be fasting for at least eight hours.
    Collection
    Separate serum from cells within two hours of collection, and transfer serum to a transfer tube.
    Labcorp catalog page
  • Hepatitis C Virus (HCV) FibroSure® 550123

    8 analytes · Serum · Fasting not stated · Turnaround 3 - 5 days

    Method and collection
    Method
    See individual test components.
    Preparation
    Patient should be fasting for at least eight hours.
    Collection
    Separate serum from cells within two hours of collection, and transfer serum to a transfer tube.
    Labcorp catalog page
  • ASH FibroSure® 550180

    12 analytes · Serum · Fasting not stated · Turnaround 3 - 6 days

    Method and collection
    Preparation
    Patient should be fasting for at least eight hours.
    Collection
    Separate serum from cells within two hours of collection, and transfer serum to a transfer tube.
    Labcorp catalog page
  • NASH FibroSure® Plus 550960

    13 analytes · Serum · Fasting not stated · Turnaround 4 - 6 days

    Method and collection
    Method
    See individual test components.
    Preparation
    Patient should be fasting for at least eight hours.
    Collection
    Separate serum from cells within two hours of collection, and transfer serum to a transfer tube.
    Labcorp catalog page
  • NASH FibroSure® With Reflex to Enhanced Liver Fibrosis (ELF)™ Test 550978

    13 analytes · Serum · Fasting not stated · Turnaround 8 - 12 days

    Method and collection
    Preparation
    Patient should be fasting for at least eight hours.
    Collection
    Complete clot formation should take place before centrifugation. Serum should be physically separated from cells as soon as possible with a maximum limit of two hours from the time of collection. Transfer serum to a transfer tube.
    Labcorp catalog page

Quest Diagnostics 1 test

Panels that include this biomarker

  • Liver Fibrosis, FibroTest-ActiTest Panel 92688

    12 analytes · Serum · Fasting not stated · Turnaround Set up: Mon-Sat; Report available: 2-5 days

    Method and collection
    Method
    Nephelometry • Spectrophotometry (SP)
    Preparation
    Overnight fasting is preferred
    Collection
    Serum should be separated from the cells as soon as possible after visible clot formation (usually 15-30 minutes after collection). Avoid freezing and thawing.
    Reference notes
    See Laboratory Report
    Quest Diagnostics catalog page

0 of 5 tests selected

Pick one more

Sources

Verify these ranges and sources

We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.

Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.